{"request_id":"1e9463787d01e37ab93deaaad580e733","results":{"ticker":"TIVC","name":"Tivic Health Systems, Inc. Common Stock","market":"stocks","locale":"us","primary_exchange":"XNAS","type":"CS","active":true,"currency_name":"usd","cik":"0001787740","composite_figi":"BBG00PT2YC04","share_class_figi":"BBG00PT2YC13","market_cap":3.0218223000000003e+06,"phone_number":"(888)276-6888","address":{"address1":"1305 E. HOUSTON STREET","address2":"BUILDING 1, SUITE 311","city":"SAN ANTONIO","state":"TX"},"description":"Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.","sic_code":"3845","sic_description":"ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS","ticker_root":"TIVC","homepage_url":"https://www.tivichealth.com","total_employees":52,"list_date":"2021-11-11","branding":{"logo_url":"https://api.polygon.io/v1/reference/company-branding/dGl2aWNoZWFsdGguY29t/images/2025-04-04_logo.png","icon_url":"https://api.polygon.io/v1/reference/company-branding/dGl2aWNoZWFsdGguY29t/images/2025-04-04_icon.jpeg"},"share_class_shares_outstanding":2877926,"weighted_shares_outstanding":2877926,"round_lot":100},"status":"OK"}